Background and Objectives The French Sentimag feasibility trial evaluated a new method
for the localization of breast cancer sentinel lymph node (SLN) using Sienna+® …

Background Sentinel lymph node (SLN) dissection involves lymphatic mapping and
selective removal of clinically negative lymph nodes at highest risk for harboring metastases …

Background Sentinel lymph node biopsy (SLNB) is a highly accurate method for staging the
axilla in early breast cancer. Superparamagnetic iron oxide mapping agents have been …

Sentinel lymph node biopsy (SLNB) is the standard surgical procedure for the axilla in early
node-negative breast cancer. To date, the “gold standard” to localize the sentinel lymph …

Aims The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …

Objective: Sentinel lymph node biopsy (SLNB) with a superparamagnetic iron oxide (SPIO)
tracer was shown to be non-inferior to the standard combined technique in the SentiMAG …

Abstract Background Preoperative injection of Tc99 is standardly performed before sentinel
lymph node biopsy (SLN) for breast cancer. Multiple questions have arisen concerning …

Abstract Background The SentiMAG Multicentre Trial evaluated a new magnetic technique
for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or …

Background Sentinel lymph node biopsy is a standard staging procedure for early axillary
lymph node‐negative breast cancer. As an alternative to the currently used radioactive …

Introduction The non-radioactive method that uses the magnetic tracer (SPIO/Sienna) has
shown to be a feasible technique for the SLN detection in breast cancer patients. The aim of …